the genetic material throughout the strand passage process. The bonds that link topoisomerase II to the DNA are established between active site tyrosyl residues on each subunit of the homodimeric enzyme and the 5'-terminal phosphates of the newly cleaved DNA strands (18) (19) (20) . Since the points of topoisomerase II-mediated scission on the two strands are staggered by four base pairs, each cleaved chain within the cleavage complex contains a four base single-stranded cohesive end at its 5'-terminus (see Fig. 1 ).
In most cases, ligases rely heavily on base pairing to correctly position the DNA termini for ligation (21, 22) . However, the covalent attachment of topoisomerase II to the 5'-termini of its ligation substrate obviates the need for base pairing. In fact, human topoisomerase IIα is able to efficiently religate substrates that contain four consecutive abasic sites within the terminal cohesive ends (thus eliminating all base pairing) (23) . On this basis, it was proposed that the type II enzyme correctly positions the 5'-DNA termini for religation through covalent protein-DNA interactions (23) .
The role of base pairing in the positioning of the 3'-DNA termini for religation is less clear. In contrast to the 5'-ends, the 3'-terminal residues remain base paired to their complementary strand following cleavage (see Fig. 1 ) (18) . Moreover, type II topoisomerases do not form covalent attachments with the 3'-DNA ends (18) . As a result, it is not obvious whether the 3'-termini are positioned for religation through base pairing. Alternatively, they may be aligned by base stacking interactions with adjacent residues or through specific noncovalent contacts with the enzyme.
If the DNA cleavage/religation cycle of eukaryotic type II topoisomerases is to Page 4 by guest on http://www.jbc.org/ Downloaded from be fully understood, it is critical to determine how the enzyme positions the DNA termini for resealing. This issue takes on further importance because it is believed that many anticancer drugs that act by inhibiting topoisomerase II-mediated DNA religation do so by displacing the 3'-DNA termini within the cleavage complex (24-26). Therefore, to address the mechanism by which the enzyme positions the 3'-DNA termini, the ability of human topoisomerase IIα to religate a series of substrates with altered base pairing or base stacking at their 3'-termini was 
EXPERIMENTAL PROCEDURES
Preparation of Oligonucleotides-A 40-base oligonucleotide corresponding to residues 87-126 of pBR322 (18, 27) 
RESULTS AND DISCUSSION
Given the importance of topoisomerase II-generated DNA breaks to the physiological and pharmacological functions of the enzyme, it is critical to understand the mechanism by which topoisomerase II reseals these breaks. During its scission event, the enzyme forms covalent bonds with the newly generated 5'-DNA termini (18) (19) (20) . Topoisomerase II utilizes these covalent interactions to align the 5'-termini of the breaks for religation ( Fig. 1 ) (23).
Since the enzyme does not form covalent bonds with the 3'-DNA termini, the basis for the alignment of the 3'-ends within the cleavage complex is not apparent.
Three major possibilities exist ( Fig. 1) . First, the 3'-termini may be positioned for religation by base pairing to their complementary DNA strands. In support of this possibility, the 3'-terminal residues are located within the duplex portion of the cleaved helix following scission (18) . Second, the 3'-termini may be positioned for religation by base stacking to their adjacent residues. In some cases, the energies of base stacking interactions approach those of base pairing (31) . Third, the 3'-termini may be positioned by noncovalent interactions with topoisomerase II. This possibility is consistent with modeling studies (based on the crystal structure of yeast topoisomerase II) and mutagenesis experiments, which suggest that there are interactions between specific amino acids and the 3'-termini generated by cleavage (32, 33) .
To distinguish between the above, the ability of human topoisomerase IIα to As a prelude to religation studies, the ability of human topoisomerase IIα to cleave the modified oligonucleotide substrates was examined (Fig. 2) . Consistent with previous studies (23, 29, 34) , the incorporation of an abasic site or a base Page 10
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http://www.jbc.org/ Downloaded from mismatch immediately outside the points of DNA cleavage decreased equilibrium levels of scission (Fig. 2) . However, even in the most dramatic case (-1 AP), levels of scission were still high enough to reproducibly monitor rates of religation. Therefore, a second abasic site was incorporated into the pBR322 substrate in order to increase the starting level of DNA cleavage. This second lesion was located within the 4-base cleavage overhang at the +2 position (Fig. 4) . Previous work indicates that the incorporation of abasic sites between the points of cleavage stimulates topoisomerase II-mediated DNA scission without affecting rates of religation (23) . As seen in Fig. 4 , following the inclusion of a +2 lesion in the top strand, levels of cleavage of the -1 abasic site oligonucleotide approached that of wild-type. Cleavage of a comparable +5,+2 bottom strand abasic substrate exceeded that of the unmodified substrate.
Similar to results obtained with the single lesion substrates, the oligonucleotide that eliminated base pairing without removing the 3'-terminal base (i.e., the +5,+2 abasic substrate) displayed wild type rates of religation (Fig. 4) . 1 Furthermore, the ability of topoisomerase II to religate the oligonucleotide that eliminated potential base stacking or protein interactions with the 3'-terminal base (i.e., the -1,+2 substrate) was severely inhibited (Fig. 4) . 2 To confirm the results found with the pBR322 substrate, cleavage and religation of a second oligonucleotide was characterized (Fig. 5 ). This second substrate was derived from a region of the MLL oncogene located proximal to a leukemic breakpoint at chromosomal band 11q23 (28, 29) . Once again, oligonucleotides included two abasic sites to avoid potential problems associated with the poor cleavage of single lesion substrates.
Cleavage levels of both the +5,+2 and -1,+4 dual abasic oligonucleotides exceeded that of wild-type ( However, religation was drastically impaired when the 3'-base was absent in the -1,+4 abasic substrate (Fig. 5) . Similar results were observed for the top strand 3'-terminus when corresponding +5,+2 and -1,+4 oligonucleotides were employed (not shown).
Effects of the 3'-Terminal Base on the DNA Cleavage/Religation Equilibrium of
Topoisomerase II-The above experiments provide strong evidence that the 3'-terminal base is important for topoisomerase II-mediated DNA religation.
However, the poor rates of religation observed for substrates that lacked this base were determined under conditions in which topoisomerase II catalyzed a unidirectional rejoining event. Therefore, an "approach to equilibrium" experiment was carried out to determine whether the lack of a 3'-terminal base also impairs religation under conditions in which topoisomerase II catalyzes a complete DNA cleavage/religation cycle.
The time required for topoisomerase II to reach its cleavage/religation equilibrium reflects both the rates of cleavage and religation. Under normal conditions, the rate of religation appears to be limiting (37) . Therefore, if the loss of the 3'-terminal base inhibits DNA religation, the time it takes for the enzyme to establish a DNA cleavage/religation equilibrium should be considerably longer than required for the comparable wild-type substrate.
As seen in removing the 3'-terminal base and displays wild type rates of religation (Fig. 4) . In contrast, when the -1,+2 abasic oligonucleotide [which eliminates the 3'-terminal base and displays dramatically lower rates of religation (Fig. 4) ] was employed, the enzyme had yet to reach equilibrium by 20 min. This finding supports the conclusion that the elimination of the 3'-terminal base impairs the religation activity of topoisomerase II. an efficiency that was similar to that of wild-type. Rates of DNA religation observed for the abasic oligonucleotide also were comparable to the unmodified sequence.
Effects
This finding argues strongly against an important role for base stacking in aligning the 3'-DNA termini for religation.
In conclusion, the DNA religation activity of topoisomerase II is critical to its physiological functions and its role as a target for anticancer agents (4) (5) (6) 8, (12) (13) (14) (15) ). Yet, the mechanism of this process is not completely understood. A previous study 
